Literature DB >> 30232126

Donor-derived MDS/AML in families with germline GATA2 mutation.

Pallavi Galera1, Amy P Hsu2, Weixin Wang1, Stephenie Droll1, Rui Chen1,3, Jason R Schwartz4, Jeffery M Klco4, Sally Arai5, Luke Maese6, Christa Zerbe2, Mark J Parta7, Neal S Young8, Steven M Holland2, Dennis D Hickstein9, Katherine R Calvo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30232126      PMCID： PMC6213320          DOI： 10.1182/blood-2018-07-861070

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

Review 1.  GATA2 deficiency.

Authors:  Amy P Hsu; Lisa J McReynolds; Steven M Holland
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-02

2.  Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications.

Authors:  Katherine R Calvo; Donald C Vinh; Irina Maric; Weixin Wang; Pierre Noel; Maryalice Stetler-Stevenson; Diane C Arthur; Mark Raffeld; Amalia Dutra; Evgenia Pak; Kyungjae Myung; Amy P Hsu; Dennis D Hickstein; Stefania Pittaluga; Steven M Holland
Journal:  Haematologica       Date:  2011-04-20       Impact factor: 9.941

3.  Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome.

Authors:  Amy P Hsu; Elizabeth P Sampaio; Javed Khan; Katherine R Calvo; Jacob E Lemieux; Smita Y Patel; David M Frucht; Donald C Vinh; Roger D Auth; Alexandra F Freeman; Kenneth N Olivier; Gulbu Uzel; Christa S Zerbe; Christine Spalding; Stefania Pittaluga; Mark Raffeld; Douglas B Kuhns; Li Ding; Michelle L Paulson; Beatriz E Marciano; Juan C Gea-Banacloche; Jordan S Orange; Jennifer Cuellar-Rodriguez; Dennis D Hickstein; Steven M Holland
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

Review 4.  Genetic predisposition to hematologic malignancies: management and surveillance.

Authors:  Lucy A Godley; Akiko Shimamura
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

5.  GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia.

Authors:  Karthik A Ganapathi; Danielle M Townsley; Amy P Hsu; Diane C Arthur; Christa S Zerbe; Jennifer Cuellar-Rodriguez; Dennis D Hickstein; Sergio D Rosenzweig; Raul C Braylan; Neal S Young; Steven M Holland; Katherine R Calvo
Journal:  Blood       Date:  2014-10-30       Impact factor: 22.113

6.  First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation.

Authors:  Haowen Xiao; Jimin Shi; Yi Luo; Yamin Tan; Jingsong He; Wanzhuo Xie; Lifei Zhang; Yingjia Wang; Lizhen Liu; Kangni Wu; Xiaohong Yu; Zhen Cai; Maofang Lin; Xiujin Ye; He Huang
Journal:  Blood       Date:  2011-03-14       Impact factor: 22.113

7.  Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome).

Authors:  Pia Ostergaard; Michael A Simpson; Fiona C Connell; Colin G Steward; Glen Brice; Wesley J Woollard; Dimitra Dafou; Tatjana Kilo; Sarah Smithson; Peter Lunt; Victoria A Murday; Shirley Hodgson; Russell Keenan; Daniela T Pilz; Ines Martinez-Corral; Taija Makinen; Peter S Mortimer; Steve Jeffery; Richard C Trembath; Sahar Mansour
Journal:  Nat Genet       Date:  2011-09-04       Impact factor: 38.330

8.  Folate-induced remission in aplastic anemia with familial defect of cellular folate uptake.

Authors:  R F Branda; C F Moldow; J R MacArthur; M M Wintrobe; B K Anthony; H S Jacob
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

9.  GATA2 deficiency and related myeloid neoplasms.

Authors:  Marcin W Wlodarski; Matthew Collin; Marshall S Horwitz
Journal:  Semin Hematol       Date:  2017-05-10       Impact factor: 3.851

10.  The evolution of cellular deficiency in GATA2 mutation.

Authors:  Rachel E Dickinson; Paul Milne; Laura Jardine; Sasan Zandi; Sabina I Swierczek; Naomi McGovern; Sharon Cookson; Zaveyna Ferozepurwalla; Alexander Langridge; Sarah Pagan; Andrew Gennery; Tarja Heiskanen-Kosma; Sari Hämäläinen; Mikko Seppänen; Matthew Helbert; Eleni Tholouli; Eleonora Gambineri; Sigrún Reykdal; Magnús Gottfreðsson; James E Thaventhiran; Emma Morris; Gideon Hirschfield; Alex G Richter; Stephen Jolles; Chris M Bacon; Sophie Hambleton; Muzlifah Haniffa; Yenan Bryceson; Carl Allen; Josef T Prchal; John E Dick; Venetia Bigley; Matthew Collin
Journal:  Blood       Date:  2013-12-17       Impact factor: 22.113
View more
  15 in total

Review 1.  The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.

Authors:  Rashmi Kanagal-Shamanna
Journal:  Curr Hematol Malig Rep       Date:  2021-05-24       Impact factor: 3.952

Review 2.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

Review 3.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 4.  Germline Predisposition to Hematolymphoid Neoplasia.

Authors:  Olga K Weinberg; Frank Kuo; Katherine R Calvo
Journal:  Am J Clin Pathol       Date:  2019-08-01       Impact factor: 2.493

Review 5.  Distinguishing constitutional from acquired bone marrow failure in the hematology clinic.

Authors:  Emma M Groarke; Neal S Young; Katherine R Calvo
Journal:  Best Pract Res Clin Haematol       Date:  2021-06-02       Impact factor: 3.670

Review 6.  Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.

Authors:  Himachandana Atluri; Yoheved S Gerstein; Courtney D DiNardo
Journal:  Curr Hematol Malig Rep       Date:  2022-10-24       Impact factor: 4.213

7.  Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.

Authors:  Inga Hofmann; Serine Avagyan; Alyssa Stetson; Dongjing Guo; Hasan Al-Sayegh; Wendy B London; Leslie Lehmann
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-20       Impact factor: 5.742

Review 8.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms.

Authors:  Jeffery M Klco; Charles G Mullighan
Journal:  Nat Rev Cancer       Date:  2020-12-16       Impact factor: 60.716

Review 9.  Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia.

Authors:  Sarah S Burns; Reuben Kapur
Journal:  Stem Cell Reports       Date:  2020-08-11       Impact factor: 7.765

10.  The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation.

Authors:  Jacquelyn A Myers; Tyler Couch; Zachary Murphy; Jeffrey Malik; Michael Getman; Laurie A Steiner
Journal:  Epigenetics Chromatin       Date:  2020-03-16       Impact factor: 4.954
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.